Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Alberto A. Gabizon"'
Autor:
Md. Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Raja Reddy Kallem, Claire Shudde, Maciej Markiewski, William C. Putnam, Alberto A. Gabizon, Ninh M. La-Beck
Publikováno v:
Biomolecules, Vol 13, Iss 9, p 1309 (2023)
While tumor-associated macrophages (TAM) have pro-tumoral activity, the ablation of macrophages in cancer may be undesirable since they also have anti-tumoral functions, including T cell priming and activation against tumor antigens. Alendronate is a
Externí odkaz:
https://doaj.org/article/57472918f48443b4b323fed7df2955d5
Autor:
Md. Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Konstantin Adamsky, Hui Yang, Carlos Alvarez, Alberto A. Gabizon, Ninh M. La-Beck
Publikováno v:
Nanotheranostics. 6:451-464
Autor:
Esther Tahover, Rachel Bar-Shalom, Eli Sapir, Raphael Pfeffer, Igor Nemirovsky, Yehonatan Turner, Maya Gips, Patricia Ohana, Benjamin W. Corn, Andrew Z. Wang, Alberto A. Gabizon
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Hypo-fractionated radiotherapy and stereotactic body radiotherapy are viable options for treatment of oligometastases. A prodrug of mitomycin-C is under clinical testing as a pegylated liposomal formulation (Promitil) with an improved safety profile
Externí odkaz:
https://doaj.org/article/87f8258574924f4cbea1e191568dfb81
Autor:
Md Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Konstantin Adamsky, Hui Yang, Carlos Alvarez, Alberto A Gabizon, Ninh M La-Beck
Publikováno v:
Cancer Immunology Research. 10:A42-A42
Although Doxorubicin is the standard of care in advanced soft tissue sarcomas, therapeutic efficacy is minimal. A major contributing factor appears to be an immunosuppressive tumor microenvironment (TME). We have shown that liposomal alendronate, an
Autor:
Patricia Ohana, Yasmine Amitay, Lidia Mak, Hilary Shmeeda, Jenny Gorin, Alberto A. Gabizon, Dina Tzemach
Publikováno v:
Cancer drug resistance (Alhambra, Calif.). 4(2)
Autor:
Alberto A, Gabizon, Esther, Tahover, Talia, Golan, Ravit, Geva, Ruth, Perets, Yasmine, Amitay, Hilary, Shmeeda, Patricia, Ohana
Publikováno v:
Investigational new drugs. 38(5)
Background Pegylated liposomal (PL) mitomycin-c lipidic prodrug MLP) may be a useful agent in patients with metastatic colo-rectal carcinoma (CRC). We report here on the pharmacokinetics and clinical observations in a phase 1A/B study with PL-MLP. Me
Autor:
Alberto A. Gabizon, Joseph Kost, Yousef Najajreh, Yechezkel Barenholz, Yeshayahu Talmon, Sarah Weisman, Yuval Avnir, Avi Schroeder
Publikováno v:
Langmuir. 23:4019-4025
The ability of low-frequency ultrasound (LFUS) to release encapsulated drugs from sterically stabilized liposomes in a controlled manner was demonstrated. Three liposomal formulations having identical lipid bilayer compositions and a similar size ( a
Autor:
Ram M. Spira, Eliahu Golomb, Oded Olsha, Oded Zmora, Amiel Segal, Moshe Carmon, Alberto A. Gabizon, Vered Avidan, Meir Goldberg
Publikováno v:
Annals of Cancer Research and Therapy. 13:26-28
Extensive axillary lymph node involvement in breast cancer patients implies poor prognosis, and is an indication for chest wall irradiation. Patients presenting with small tumors and a negative axillary status clinically, are expected to have a good
Autor:
Alberto A. Gabizon
Publikováno v:
Nanotechnology for Cancer Therapy ISBN: 9780429123375
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b2a4cbb6481b05dbc644799894c15b0
https://doi.org/10.1201/9781420006636-29
https://doi.org/10.1201/9781420006636-29
Autor:
Alberto A. Gabizon
Publikováno v:
Nanoparticulates as Drug Carriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bc1e4ab20fa74fedd9a80cc9f186286
https://doi.org/10.1142/9781860949074_0020
https://doi.org/10.1142/9781860949074_0020